摘要 |
Use of an agent which interacts with 5HT receptors as defined herein for the preparation of a medicament for restoring, alleviation, or treatment of immunodeficiency, which can be related to major surgical procedures, blood transfusions, cancer or virus infections with Epstein Barr virus (EBV), Cytomegalo virus (CMV), measles virus, varicella virus or to infection with Human Immunodeficiency Viruses (HIV) or related viruses, e.g. as seen in pre-AIDS and AIDS. The interaction may be via an immune cell receptor, e.g. present on T cells, said receptor being structurally or functionally related to the 5HT receptors or subtypes thereof present on cells in the nervous system.
|